F
A. Cabré et al.
Special Topic
Synthesis
1H NMR (400 MHz, CDCl3): δ = 7.53 (ddd, J = 4.6, 2.7, 1.9 Hz, 1 H), 4.37
(td, J = 2.8, 1.8 Hz, 2 H), 2.66–2.57 (m, 2 H), 2.54–2.42 (m, 2 H), 0.92 (s,
9 H), 0.08 (s, 6 H).
HRMS (ESI): m/z [M + H]+ calcd for C14H15O3: 231.1016; found:
231.1022.
Ethyl 2-(2-{[(tert-Butyldimethylsilyl)oxy]methyl}-5-oxocyclo-
pent-1-en-1-yl)acetate (8i)
The analytical and spectral data for this compound were in excellent
agreement with the reported data.24
Starting from 0.22 mmol scale of Co complex 1i; isolated yield; Meth-
od B: 34 mg (49%); Method C: 29 mg (43%); colorless oil.
4-Methyl-N-[(5-oxocyclopent-1-en-1-yl)methyl]benzenesulfon-
IR (ATR-FTIR): 2958, 2923, 2856, 1734, 1702 cm–1
.
amide (7f)
Starting from 0.22 mmol of Co complex 1f; isolated yield; Method B:
43 mg (72%); Method C: 38 mg (64%); colorless oil.
1H NMR (400 MHz, CDCl3): δ = 4.58 (s, 2 H), 4.12 (q, J = 7.1 Hz, 2 H),
3.32 (s, 2 H), 2.64 (dtd, J = 7.1, 2.3, 1.2 Hz, 2 H), 2.44–2.39 (m, 2 H),
1.25 (t, J = 7.1 Hz, 3 H), 0.92 (s, 9 H), 0.10 (s, 6 H).
IR (ATR-FTIR): 3270, 3017, 1689 cm–1
.
1H NMR (400 MHz, CDCl3): δ = 7.73–7.68 (m, 2 H), 7.41 (tt, J = 2.7, 1.3
Hz, 1 H), 7.32–7.27 (m, 2 H), 5.14 (t, J = 6.4 Hz, 1 H), 3.80 (dtd, J = 6.6,
1.8, 1.2 Hz, 2 H), 2.51–2.45 (m, 2 H), 2.42 (s, 3 H), 2.28–2.24 (m, 2 H).
13C NMR (101 MHz, CDCl3): δ = 208.41, 174.71, 170.44, 132.66, 62.44,
61.04, 33.80, 28.67, 27.55, 25.95, 18.46, 14.30, –5.40.
HRMS (ESI): m/z [M + H]+ calcd for C16H29O4Si: 313.1830; found:
313.1834.
13C NMR (101 MHz, CDCl3): δ = 208.98, 160.31, 143.48, 140.71,
136.93, 129.60, 127.24, 39.18, 34.53, 26.87, 21.49.
HRMS (ESI): m/z [M + H]+ calcd for C13H16NO3S: 266.0845; found
tert-Butyl [(1-Oxo-1,3a,4,5,6,6a-hexahydropentalen-2-yl)meth-
yl]carbamate (11b)
266.0844.
Starting from 0.23 mmol of Co complex 1b; isolated yield; Method A:
20 mg (35%); Method B: 35 mg (60%); colorless oil.
3-{[(tert-Butyldimethylsilyl)oxy]methyl}-2-propylcyclopent-2-
IR (ATR-FTIR): 2937, 2869, 1724, 1525, 758 cm–1
.
en-1-one (8d)
Starting from 0.18 mmol of Co complex 1d; isolated yield; Method B
(using 10 equiv of NMO): 6 mg (12%); colorless oil.
1H NMR (400 MHz, CDCl3): δ = 7.32–7.26 (m, 1 H), 5.02 (br s, 1 H),
3.86 (d, J = 6.2 Hz, 2 H), 3.33–3.18 (m, 1 H), 2.74 (ddd, J = 10.1, 5.6, 1.8
Hz, 1 H), 1.91–1.83 (m, 1 H), 1.75–1.65 (m, 2 H), 1.63–1.54 (m, 2 H),
1.42 (s, 9 H), 1.19 (qt, J = 12.4, 6.5 Hz, 1 H).
13C NMR (101 MHz, CDCl3): δ = 212.36, 162.22, 155.79, 143.11, 79.44,
50.51, 44.25, 36.04, 30.07, 29.35, 28.33, 23.55.
IR (ATR-FTIR): 2950, 1770, 1464, 840 cm–1
.
1H NMR (400 MHz, CDCl3): δ = 4.54 (s, 2 H), 2.59 (dtd, J = 7.1, 2.3, 1.2
Hz, 2 H), 2.41–2.33 (m, 2 H), 2.21–2.10 (m, 2 H), 1.39 (dq, J = 14.8, 7.4
Hz, 2 H), 0.92 (s, 9 H), 0.87 (t, J = 7.4 Hz, 3 H), 0.10 (s, 6 H).
13C NMR (101 MHz, CDCl3): δ = 210.07, 171.72, 139.49, 61.36, 34.19,
HRMS (ESI): m/z [M + H]+ calcd for C14H22NO3: 252.1594; found:
27.09, 25.96, 25.20, 21.91, 18.47, 14.20, –5.29.
252.1591.
HRMS (ESI): m/z [M + H]+ calcd for C15H29O2Si: 269.1931; found:
269.193.
2-(Trimethylsilyl)-4,5,6,6a-tetrahydropentalen-1(3aH)-one (11c)
Starting from 0.23 mmol of Co complex 1c; isolated yield; Method A:
7 mg (16%); Method B: 14 mg (31%); colorless oil.
Ethyl 2-(2-{[(tert-Butoxycarbonyl)amino]methyl}-5-oxocyclo-
IR (ATR-FTIR): 2918, 2850, 1734, 1215, 758 cm–1
.
pent-1-en-1-yl)acetate (8g)
Starting from 0.23 mmol of Co complex 1g; isolated yield; Method A:
14 mg (20%); Method B: 43 mg (64%); Method C: 37 mg (56%); color-
less oil.
1H NMR (400 MHz, CDCl3): δ = 7.57 (d, J = 2.6 Hz, 1 H), 3.30 (ddt, J =
8.5, 5.4, 2.5 Hz, 1 H), 2.71–2.62 (m, 1 H), 1.89 (dd, J = 12.7, 6.3 Hz, 1 H),
1.75–1.61 (m, 2 H), 1.56 (dt, J = 12.5, 6.0 Hz, 2 H), 1.13 (ddq, J = 18.8,
12.5, 6.4 Hz, 1 H), 0.16 (s, 9 H).
IR (ATR-FTIR): 3359, 2972, 1701, 1693, 1650 cm–1
.
1H NMR (400 MHz, CDCl3): δ = 5.05 (br s, 1 H), 4.17–4.10 (m, 2 H),
4.12 (s, 2 H), 3.30 (s, 2 H), 2.69–2.58 (m, 2 H), 2.48–2.40 (m, 2 H), 1.46
(s, 9 H), 1.25–1.28 (m, 3 H).
13C NMR (101 MHz, CDCl3): δ = 216.84, 174.91, 147.66, 50.81, 47.85,
30.60, 29.75, 23.50, –1.64.
HRMS (ESI): m/z [M + H]+ calcd for C11H19OSi: 195.1200; found:
195.1197.
13C NMR (101 MHz, CDCl3): δ = 208.04, 172.77, 171.21, 170.73,
156.13, 134.01, 80.01, 61.29, 60.46, 40.85, 33.90, 28.42, 21.11, 14.27.
HRMS (ESI): m/z [M + H]+ calcd for C15H24NO5: 298.1649; found:
tert-Butyl [(6-Oxo-3,3a,6,6a-tetrahydro-2H-cyclopenta[b]furan-5-
yl)methyl]carbamate (12b)
298.1650.
Starting from 0.23 mmol of Co complex 1b; isolated yield; Method A:
23 mg (40%); Method B: 33 mg (57%); colorless oil.
Methyl 2-Benzyl-3-oxocyclopent-1-ene-1-carboxylate (8h)
Starting from 0.36 mmol of Co complex 1h; isolated yield; Method A:
IR (ATR-FTIR): 2955, 2917, 2850, 1715, 1168, 758 cm–1
.
9 mg (11%); Method B: 36 mg (46%); colorless oil.
1H NMR (400 MHz, CDCl3): δ = 7.35 (d, J = 2.7 Hz, 1 H), 5.02 (br s, 1 H),
4.33 (d, J = 5.6 Hz, 1 H), 3.96 (ddd, J = 9.3, 7.4, 2.0 Hz, 1 H), 3.88 (d, J =
6.9 Hz, 2 H), 3.56–3.48 (m, 1 H), 3.46–3.38 (m, 1 H), 2.07 (dddd, J =
10.9, 7.5, 3.4, 2.2 Hz, 1 H), 1.79 (ddt, J = 12.6, 5.4, 2.1 Hz, 1 H), 1.41 (s,
9 H).
13C NMR (101 MHz, CDCl3): δ = 206.00, 159.05, 155.76, 143.56, 80.48,
67.48, 42.88, 35.96, 30.06, 28.31.
IR (ATR-FTIR): 2976, 2954, 1715, 1709 cm–1
.
1H NMR (400 MHz, CDCl3): δ = 7.30 (ddt, J = 7.6, 1.5, 0.7 Hz, 2 H),
7.27–7.21 (m, 2 H), 7.20–7.14 (m, 1 H), 3.91 (s, 2 H), 3.87 (s, 3 H),
2.81–2.75 (m, 2 H), 2.50–2.44 (m, 2 H).
13C NMR (101 MHz, CDCl3): δ = 209.03, 165.57, 154.54, 149.60,
138.28, 129.00, 128.36, 126.32, 52.14, 33.97, 29.65, 26.65.
HRMS (ESI): m/z [M + H]+ calcd for C13H20NO4: 254.1387; found:
254.1382.
© Georg Thieme Verlag Stuttgart · New York — Synthesis 2017, 49, A–G